Salti GI - Search Results

1

Outcomes of surgery for dermatofibrosarcoma protuberans.

Chang CK, Jacobs IA, Salti GI. Chang CK, et al. Among authors: salti gi. Eur J Surg Oncol. 2004 Apr;30(3):341-5. doi: 10.1016/j.ejso.2003.12.005. Eur J Surg Oncol. 2004. PMID: 15028319

2

Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanoma.

Jacobs IA, Chang CK, DasGupta TK, Salti GI. Jacobs IA, et al. Among authors: salti gi. Ann Surg Oncol. 2003 Jun;10(5):558-61. doi: 10.1245/aso.2003.10.025. Ann Surg Oncol. 2003. PMID: 12794023 Clinical Trial.

3

Primary malignant melanoma of the lip.

Froix AJ, Salti GI. Froix AJ, et al. Among authors: salti gi. J Surg Oncol. 2003 Sep;84(1):7-9. doi: 10.1002/jso.10285. J Surg Oncol. 2003. PMID: 12949984

4

Melanoma in the elderly patient.

Chang CK, Jacobs IA, Vizgirda VM, Salti GI. Chang CK, et al. Among authors: salti gi. Arch Surg. 2003 Oct;138(10):1135-8. doi: 10.1001/archsurg.138.10.1135. Arch Surg. 2003. PMID: 14557133

5

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal sarcomatosis.

Salti GI, Ailabouni L, Undevia S. Salti GI, et al. Ann Surg Oncol. 2012 May;19(5):1410-5. doi: 10.1245/s10434-012-2240-7. Ann Surg Oncol. 2012. PMID: 22302269

6

The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.

Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spilioitis J, Torres-Melero J, Turaga K, Trout R. Esquivel J, et al. Ann Surg Oncol. 2014 Dec;21(13):4195-201. doi: 10.1245/s10434-014-3798-z. Epub 2014 May 23. Ann Surg Oncol. 2014. PMID: 24854493

7

The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.

Prada-Villaverde A, Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spiliotis J, Torres-Melero J, Turaga K, Trout R. Prada-Villaverde A, et al. J Surg Oncol. 2014 Dec;110(7):779-85. doi: 10.1002/jso.23728. Epub 2014 Aug 2. J Surg Oncol. 2014. PMID: 25088304

8

Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge.

Bhagwandin SB, Naffouje S, Salti G. Bhagwandin SB, et al. J Surg Oncol. 2015 Mar;111(3):324-7. doi: 10.1002/jso.23834. Epub 2014 Dec 31. J Surg Oncol. 2015. PMID: 25557653

9

Utility of Chemoresponse Assay in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy.

Bhagwandin S, Naffouje S, Salti G. Bhagwandin S, et al. Ann Surg Oncol. 2015 Aug;22(8):2573-7. doi: 10.1245/s10434-014-4330-1. Epub 2015 Jan 9. Ann Surg Oncol. 2015. PMID: 25572680

10

Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting: A cost-utility analysis of a hospital's initial experience and reflections on the health care system.

Naffouje SA, O'Donoghue C, Salti GI. Naffouje SA, et al. Among authors: salti gi. J Surg Oncol. 2016 Apr;113(5):544-7. doi: 10.1002/jso.24162. Epub 2016 Jan 11. J Surg Oncol. 2016. PMID: 26750613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results